Presented during the Immuno-Oncology 360° conference, this presentation provides the third-party perspective on operational aspects of immuno-oncology trials, including PDL1 stratification and biomarkers. Q² Solutions presented as part of a collaborative talk with a panel discussion.

Q² Solutions has a unique role in immuno-oncology drug development, with clinical laboratory services continually evolving to provide clear results that meet regulatory standards and drive confident decisions for customers.

Download this presentation to learn more.

Speaker:
Patrice Hugo, Ph.D., Chief Scientific Officer

Panelists:
Howard Grossberg, MD, Senior Medical Director, Oncology Center of Excellence, IQVIA
Jeff Hodge, VP, Development Solutions, Oncology Center of Excellence, IQVIA